Dividend policy issues in the European pharmaceutical industry : new empirical evidence
Year of publication: |
2023
|
---|---|
Authors: | Basse, Tobias ; Schwarzbach, Christoph ; Schulenburg, Johann-Matthias von der |
Published in: |
The European journal of health economics. - Berlin : Springer, ISSN 1618-7601, ZDB-ID 2011428-X. - Vol. 24.2023, 5, p. 803-816
|
Subject: | Dividend policy | Granger causality | Health care firms | Litigation risk | Pharmaceutical industry | Research and development expenditures | Pharmaindustrie | Dividende | Dividend | Industrieforschung | Industrial research | EU-Staaten | EU countries | Gesundheitskosten | Health care costs | Arzneimittel | Pharmaceuticals |
-
Dividend policy issues in the European pharmaceutical industry: new empirical evidence
Basse, Tobias, (2022)
-
Effects of cost containment on pharmaceutical innovation
Hansen, Ronald W., (1986)
-
Pharmacoeconomics in perspective : a primer on research, techniques, and information
Bonk, Robert J., (1999)
- More ...
-
Hauptschriften zur Versicherungs- und Finanzmathematik
Leibniz, Gottfried Wilhelm, (2000)
-
Auswirkungen der EU-Vermittlerrichtlinie auf die deutsche Vermittlerlandschaft
Schwarzbach, Christoph, (2011)
-
Chancen und Herausforderungen der Rückversicherung in der gesetzlichen Krankenversicherung
Schwarzbach, Christoph, (2012)
- More ...